Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-19
DOI
10.1038/s41467-021-24609-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial DNA in inflammation and immunity
- (2020) Joel S Riley et al. EMBO REPORTS
- TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9
- (2020) Leonhard X. Heinz et al. NATURE
- Inhibition of IRF5 hyperactivation protects from lupus onset and severity
- (2020) Su Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Management strategies and future directions for systemic lupus erythematosus in adults
- (2019) Laura Durcan et al. LANCET
- Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells
- (2019) Charles-Antoine Dutertre et al. IMMUNITY
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of age-associated B cells by IRF5 in systemic autoimmunity
- (2018) Michela Manni et al. NATURE IMMUNOLOGY
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
- (2018) Susan Malkiel et al. Frontiers in Immunology
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2018) Scott A. Jenks et al. IMMUNITY
- When to use belimumab in SLE
- (2017) Mariele Gatto et al. Expert Review of Clinical Immunology
- Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
- (2017) Wei Gao et al. Frontiers in Physiology
- Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
- (2016) Romain Banchereau et al. CELL
- Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity
- (2016) Tatsuma Ban et al. IMMUNITY
- New insights into the immunopathogenesis of systemic lupus erythematosus
- (2016) George C. Tsokos et al. Nature Reviews Rheumatology
- Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease
- (2016) Hayley L. Eames et al. Translational Research
- IRF5 Deficiency Ameliorates Lupus but Promotes Atherosclerosis and Metabolic Dysfunction in a Mouse Model of Lupus-Associated Atherosclerosis
- (2015) Amanda A. Watkins et al. JOURNAL OF IMMUNOLOGY
- Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN- Production in Women
- (2015) M. Griesbeck et al. JOURNAL OF IMMUNOLOGY
- Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis
- (2015) Chandra Mohan et al. Nature Reviews Nephrology
- The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression
- (2015) T. Hung et al. SCIENCE
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Immunopathogenic mechanisms of systemic autoimmune disease
- (2013) Marie Wahren-Herlenius et al. LANCET
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response
- (2012) C-M Fang et al. GENES AND IMMUNITY
- Pleiotropic IFN-Dependent and -Independent Effects of IRF5 on the Pathogenesis of Experimental Lupus
- (2012) Y. Xu et al. JOURNAL OF IMMUNOLOGY
- Taming lupus—a new understanding of pathogenesis is leading to clinical advances
- (2012) Zheng Liu et al. NATURE MEDICINE
- Global Trend of Survival and Damage of Systemic Lupus Erythematosus: Meta-Analysis and Meta-Regression of Observational Studies from the 1950s to 2000s
- (2012) Anselm Mak et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Unmet medical needs in systemic lupus erythematosus
- (2012) Aisha Lateef et al. ARTHRITIS RESEARCH & THERAPY
- IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus
- (2011) Timothy B Niewold et al. ANNALS OF THE RHEUMATIC DISEASES
- Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons
- (2011) Rivka C. Stone et al. ARTHRITIS AND RHEUMATISM
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus
- (2010) D. A. Savitsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- IFN Regulatory Factor 5 Is Required for Disease Development in the Fc RIIB-/-Yaa and Fc RIIB-/- Mouse Models of Systemic Lupus Erythematosus
- (2009) C. Richez et al. JOURNAL OF IMMUNOLOGY
- Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease
- (2009) H. Agrawal et al. JOURNAL OF IMMUNOLOGY
- The IRF Family Transcription Factors in Immunity and Oncogenesis
- (2008) Tomohiko Tamura et al. Annual Review of Immunology
- Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients
- (2008) Timothy B. Niewold et al. ARTHRITIS AND RHEUMATISM
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More